FDA Classifies a Mechanical Device That Helps Clear Congestion
Published Date: 11/6/2026
Rule
Summary
The FDA is officially classifying the external mechanical stimulator for congestion relief as a Class II device, meaning it now has special safety rules but fewer regulatory hurdles. This change helps patients get access to these devices faster and ensures they’re safe and effective. The new classification took effect on November 6, 2026, with the rules applying retroactively from December 4, 2023.
Analyzed Economic Effects
4 provisions identified: 3 benefits, 1 costs, 0 mixed.
Device now Class II — faster access
The FDA officially classified the external mechanical stimulator for relief of congestion as Class II (special controls). The order is effective November 6, 2026, and the classification was applicable on December 4, 2023; FDA says this classification provides a reasonable assurance of safety and will enhance patients' access by reducing regulatory burdens.
Device subject to 510(k) premarket notification
Because the device is classified into Class II, it is subject to premarket notification under section 510(k) of the Federal Food, Drug, and Cosmetic Act unless FDA exempts it. The final order states FDA has not determined an exemption for external mechanical stimulators for relief of congestion, so sponsors must submit a 510(k).
De Novo classification creates predicate for others
FDA states that because this device was classified via the De Novo process, it can serve as a predicate device for future devices of the same type, allowing other sponsors to use the less burdensome 510(k) process rather than a De Novo request or premarket approval. That change can reduce regulatory burdens for future device sponsors.
Mandatory safety, testing, and labeling rules
The final order lists special controls manufacturers must meet, including non-clinical performance testing, electromagnetic compatibility, battery and electrical safety testing, software verification/validation and hazard analysis, biocompatibility evaluation of patient-contacting parts, human factors testing, and specific labeling (including frequency range, maximum output power, power source, and an explanation of the user interface).
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-20848, Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods
The FDA is changing food rules to allow salt substitutes in many standardized foods, helping companies make lower-sodium options. This move aims to cut heart disease risks by reducing sodium without changing how foods basically taste or look. The new rule kicks in December 14, 2026, and food makers have until November 12, 2026, to raise any concerns, with no big costs expected.
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2025-04978, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA is delaying a new rule about nonprescription drugs that have extra conditions for use. Originally set to start on March 21, 2025, the rule’s start date is now pushed back to May 27, 2025, to allow more time for review. This affects drug makers and consumers by giving everyone extra time to prepare for the new requirements without any immediate cost changes.
2025-01840, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA’s new rule about nonprescription drugs needing extra conditions before use was set to start on January 27, 2025, but it’s now delayed until March 21, 2025. This delay follows a presidential order to pause and review new rules before they take effect. Drug makers, sellers, and consumers should note the new start date and get ready for the updated rules soon.
Previous / Next Documents
Previous: 2026-22649, Cost Standards and Procedures; Purchasing and Property Management
The Legal Services Corporation is updating its rules on how grant recipients manage money and property. They’re raising the spending limit that needs prior approval, making paperwork simpler, and clarifying how to handle fundraising money. These changes start June 1, 2027, and aim to make managing federal funds easier and more consistent for everyone involved.
Next: 2026-22663, Food Additive Petitions; Change of Address
The FDA updated the address and notification rules for food additive petitions to keep things accurate and simple. This change affects anyone submitting petitions about animal food additives and takes effect immediately on November 6, 2026. No fees or big changes—just a smoother process for sending in your paperwork!